iShares Biotechnology ETF (NASDAQ:IBB) Shares Bought by Jones Financial Companies Lllp

Jones Financial Companies Lllp lifted its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 68.0% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 17,521 shares of the financial services provider’s stock after acquiring an additional 7,089 shares during the period. Jones Financial Companies Lllp’s holdings in iShares Biotechnology ETF were worth $2,316,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also made changes to their positions in IBB. BNP Paribas Financial Markets raised its position in iShares Biotechnology ETF by 29.3% during the third quarter. BNP Paribas Financial Markets now owns 2,380,229 shares of the financial services provider’s stock worth $346,561,000 after acquiring an additional 538,899 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund increased its stake in shares of iShares Biotechnology ETF by 32.9% during the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 663,000 shares of the financial services provider’s stock worth $96,533,000 after purchasing an additional 164,000 shares in the last quarter. Aprio Wealth Management LLC acquired a new position in shares of iShares Biotechnology ETF during the 4th quarter worth approximately $18,476,000. DRW Securities LLC purchased a new stake in iShares Biotechnology ETF in the 3rd quarter valued at approximately $5,990,000. Finally, Erste Asset Management GmbH acquired a new stake in iShares Biotechnology ETF during the 3rd quarter valued at $5,678,000. 62.45% of the stock is currently owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Stock Up 1.8 %

NASDAQ IBB opened at $136.79 on Thursday. iShares Biotechnology ETF has a fifty-two week low of $123.60 and a fifty-two week high of $150.57. The business has a fifty day moving average of $135.93 and a 200-day moving average of $140.46. The stock has a market cap of $6.46 billion, a price-to-earnings ratio of 24.52 and a beta of 0.84.

iShares Biotechnology ETF Cuts Dividend

The company also recently announced a dividend, which was paid on Friday, December 20th. Investors of record on Tuesday, December 17th were paid a $0.0624 dividend. The ex-dividend date was Tuesday, December 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.